Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cansino Biologics Inc (OP: CASBF )

3.220 +0.650 (+25.29%)
Streaming Delayed Price Updated: 3:29 PM EDT, Sep 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,560
Open 2.900
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 2.570
Today's Range 2.900 - 3.220
52wk Range 1.860 - 3.550
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CanSinoBIO Reports Outstanding H1 2024 Performance
Via ACN Newswire
Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership
BeiGene and Bristol-Myers Squibb have formally completed the breakup of the BeiGene-Celgene partnership, returning 23.3 million ordinary BeiGene shares to BeiGene. Meanwhile, Gracell Biotechnologies... 
Via Talk Markets

Performance

YTD
+20.37%
+20.37%
1 Month
+28.03%
+28.03%
3 Month
+34.17%
+34.17%
6 Month
+53.33%
+53.33%
1 Year
+10.27%
+10.27%

More News

Read More
Why Is CanSino Biologics (CASBF) Stock Soaring Today?
Via InvestorPlace
Week In Review: Fosun Acquires VerImmune Cancer Immunotherapy In $125 Million Deal
Via Talk Markets
Week In Review: Shanghai Regor To Discover Metabolic Therapies For Lilly In $1.55 Billion Deal
Via Talk Markets
Week In Review: Zai Lab Raises $750 Million In Private Placement For In-Licensed/Novel Drugs
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.